AIDS patients who frequently suffer from diarrhea may now finally see some light at the end of the tunnel for a new drug developed to help them.The U.S. Food and Drug Administration has granted priority review for Salix Pharmaceuticals‘ (NASDAQ:SLXP) crofelemer and an approval decision on the drug candidate could come by June 5. That [...]

Generic competition for GlaxoSmithKline (NYSE:GSK) AIDS drug Epzicom is on its way around the world, if not the United States. Yet.The U.S. Food and Drug Administration has given tentative approval for a formulation of the drug made by Cipla, a pharmaceutical company based in Mumbai, India. The tentative approval comes under expedited review from the [...]

Gastrointestinal therapeutics firm Salix Pharmaceuticals (NASDAQ:SLXP) is pressing ahead with a drug candidate to treat diarrhea in AIDS patients despite a deteriorating relationship with its drug partner that has led to a contract dispute and dueling lawsuits.Raleigh, North Carolina-based Salix today filed a New Drug Application for crofelemer, a filing that comes more than a [...]

AIDS research efforts at Duke University have landed three grants totaling $37.2 million from the Bill & Melinda Gates Foundation.The grants will fund Duke University Medical Center HIV work in the Collaboration for AIDS Vaccine Discovery (CAVD) program, an international network of scientists working to bring new HIV vaccine candidates into clinical trials. The CAVD [...]

As a physician, I’ve cared for people living with HIV/AIDS for more than two decades. And as I honor World AIDS this December 1, I’ll remember the many people affected by this disease that have changed my life. Each faced unique challenges and struggles. Many demonstrated remarkable resilience. Everyone reminded me of how quickly life [...]

Current medical news from today, including a new HIV vaccine looks promising in animal tests, Onyx Pharmaceuticals rumored to be seeking a buyer, and the many challenges of being a healthcare CEO.

Current medical news from today, including HIV prevention gel for women surprises researchers by failing in a trial, EndoStapling system gets FDA nod, and Supreme Court justices questioned over ethics.

Salix Pharmaceuticals‘ (NASDAQ:SLXP) drug partner Napo Pharmaceuticals has terminated the collaboration agreement between the two companies over Salix’s failure to advance a promising anti-diarrhea drug for AIDS patients fast enough for the California company.Termination of the collaboration to develop the drug candidate crofelemer was effective Nov. 4 — a year to the date of positive [...]

Current medical news from today, including encouraging news for HIV prevention, the Small Business Jobs Act one year later, and tracking how a virus transfers species.

GlaxoSmithKline (NYSE:GSK) is moving to protect its top-selling HIV drug Epzicom from generic drug competition.ViiV Healthcare, the HIV joint venture of GSK and Pfizer (NYSE:PFE), is suing Teva Pharmaceutical (NASDAQ:TEVA) for infringing on HIV drug Epzicom in violation of the drug’s patent, Bloomberg News reports. The Aug. 5 complaint was filed in federal court in [...]